This document summarizes a report on the pipeline of therapeutics under development for endometriosis. There are currently 4 molecules in Phase III trials, 10 in Phase II, and 15 in Phase I or earlier stages of development for endometriosis according to the report. The pipeline guide provides detailed profiles of each therapeutic in development and tracks companies, universities, and molecules involved in research. It is intended to help identify emerging players, create effective strategies, and stay informed of developments to treat endometriosis.

1. Endometriosis - Pipeline Review, H2 2018
View Complete Report https://www.reportsnreports.com/reports/1674803-
endometriosis-pipeline-review-h2-2018.html
Published By -> Global Markets Direct
Published on -> September 2018
No. of Pages -> 135

2. Endometriosis - Pipeline Review, H2 2018
Introduction:
Pharmaceutical and Healthcare latest pipeline guide Endometriosis Market - Pipeline
Review, H2 2018, provides comprehensive information on the therapeutics under
development for Endometriosis (Women's Health), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and
press releases.
Endometriosis is an often painful disorder in which tissue that normally lines the
inside of uterus (endometrium) grows outside uterus (endometrial implant).
Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and
abnormal bleeding. Risk factors age, uterine abnormalities, history of pelvic infection
and family history. Treatment includes NSAIDs, birth control pills and progestins.

3. Report Highlights
The Endometriosis (Women's Health) pipeline guide also reviews of key players
involved in therapeutic development for Endometriosis and features dormant and
discontinued projects. The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules developed by Companies in Phase
III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4,
10, 15, 2, 12, 3 and 2 respectively. Similarly, the Universities portfolio in Phase II,
Preclinical and Discovery stages comprises 1, 3 and 3 molecules, respectively.
Endometriosis (Women's Health) pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios, enhances decision making
capabilities and helps to create effective counter strategies to gain competitive
advantage. The guide is built using data and information sourced from proprietary
databases, company/university websites, clinical trial registries, conferences, SEC
filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources. Additionally, various dynamic tracking
processes ensure that the most recent developments are captured on a real time
basis.
Endometriosis - Pipeline Review, H2 2018

4. Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of
Endometriosis (Women's Health).
- The pipeline guide reviews pipeline therapeutics for Endometriosis (Women's Health)
by companies and universities/research institutes based on information derived from
company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development
ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which
comprise, product description, descriptive licensing and collaboration details, R&D
brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Endometriosis (Women's
Health) therapeutics and enlists all their major and minor projects.
Click here to know more about Endometriosis Market Pipeline research report @
https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1674803
Endometriosis - Pipeline Review, H2 2018

5. Reasons to buy
- Procure strategically important competitor information, analysis, and insights to
formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development
for Endometriosis (Women's Health).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most
promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Endometriosis
(Women's Health) pipeline depth and focus of Indication therapeutics.
Buy a copy of Endometriosis Market research report @
https://www.reportsnreports.com/purchase.aspx?name=1674803
Endometriosis - Pipeline Review, H2 2018

6. Single User License: US $ 2000 Corporate User License: US $ 6000
About Us:
ReportsnReports.com is your single source for all market research needs. Our database
includes 500,000+ market research reports from over 95 leading global publishers & in-
depth market research studies of over 5000 micro markets. With comprehensive information
about the publishers and the industries for which they publish market research reports, we
help you in your purchase decision by mapping your information needs with our huge
collection of reports.
Email us @ sales@reportsandreports.com Call us + 1 888 391 5441
Endometriosis - Pipeline Review, H2 2018